SNX1 and meningioma: The trends of gene expression profiles of candidates such as EFCAB2, EPS8L1, NOL3, PAIP1 and SNX1 showed elevated expression in meningiomas compared to controls, while CAMK2N1, CRYM and PRPSAP2 showed decreased expression levels in meningiomas compared to the controls.